| Metric | Value (₹ Cr) | vs Q1 FY27 |
|---|---|---|
| Revenue | 745.95 | 4.1% |
| Total Income | 751.95 | 4.7% |
| Expenditure | 713.88 | 9.4% |
| PBT | 38.07 | 41.7% |
| Net Profit | 29.56 | 41.4% |
| OPM | 5.70% | 4.27pp |
| NPM | 3.93% | 3.10pp |
| EPS | 3.99 | 43.0% |
Revenue soars 73% but profit collapses 32% — margin promise unfulfilled
Shanti Gold reported exceptional top-line growth driven by volume expansion and retail formalization, yet profitability plummeted 32.5% year-over-year. Management's own Q2 PAT claims contradict the delivered result—a credibility gap the market is pricing in.
₹746 Cr
+73.4% YoY vs. ₹430 Cr prior year
₹29.6 Cr
−32.5% YoY vs. ₹43.9 Cr implied
5.7%
Guided 5–7%, prior 7.5–8%
41% YoY
535.5 kg in Q2; +25.4% Q2 YoY
On the surface, Shanti Gold delivered a blowout quarter—₹746 crore in revenue, a 73% leap year-over-year and 102% growth for the half. The story fractures below the line. Net profit fell 32.5% despite the revenue surge, and management has cut EBITDA margin guidance to a 5–7% range from its prior 7.5–8% target. The gap between headline growth and profitability collapse defines the quarter—and raises hard questions about execution and margin recovery.
The claims vs. what holds up
Management's commentary during the call made a series of claims about growth and profitability. Here is what the delivered result and the numbers actually show:
Q2 PAT growth 13.5% YoY
Delivered result ₹29.6 Cr vs. implied prior-year ₹43.9 Cr = −32.5% YoY
Contradicted (high severity)
H1 PAT growth 32.5% YoY
If Q2 is −32.5% and H1 is +32.5%, Q1 must have +98% growth; not separately disclosed
Contradicted (math inconsistent)
EBITDA growth 15.6% Q2, 29.2% H1
₹42.5 Cr Q2 EBITDA confirmed; growth supported but margin % compressed below guidance
Supported (but margin miss)
Volume up 25.4% YoY Q2, 41% H1
535.5 kg confirmed; growth narrative consistent with retail formalization tailwind
Supported
FY27 revenue guidance ₹3,500 Cr unchanged
Revised to ₹3,200–3,500 Cr range; prior was point estimate ₹3,500 Cr
Overstated (guidance narrowed)
Sustainable EBITDA margin 7.5–8%
Management now guiding 5–7%; explicit cut from prior lower bound of 7.5%
Contradicted
What changed on this call
Shanti Gold stepped back on two material fronts. EBITDA margin guidance was cut to 5–7% from the prior 7.5–8% target. Management frames this as temporary—a product-mix transition and scale-up cost absorption—but it is a concrete downgrade. FY27 revenue was narrowed to a ₹3,200–3,500 crore range from a prior point estimate of ₹3,500 crore, signalling macro caution and the impact of capex delays. Jaipur facility operationalization was pushed back to January–February 2027 from the original November–December timeline. Interior fit-out is ongoing; the 1,200 kg annual capacity addition will now contribute less to H2 FY27 performance. Debt-to-equity was lifted from a 0.5x comfort zone to a target of 1x, expanding leverage to fund growth capex, inventory, and the Dubai office setup. Product mix has expanded to include designer, Turkish, and CZ jewelry lines, a deliberate diversification away from plain gold only—but one carrying near-term margin headwinds.
73% revenue growth driven by volume expansion and retail formalization tailwind
41% volume growth (H1 YoY) shows strong demand from organized retail partners
Marol facility ramp proves capex execution; Jaipur adds 1,200 kg capacity
Product diversification (designer, Turkish, CZ) and export growth (6–7% target) credible
PAT collapsed 32.5% YoY despite 73% revenue growth—margin pressure acute
Management Q2 PAT claim (+13.5% growth) contradicts delivered result (−32.5%)
EBITDA margin guidance cut to 5–7% from 7.5–8%; credibility grade C
Jaipur facility delayed to Jan–Feb from Nov–Dec; execution risk
Inventory buildup (₹13,500/gram) for product launches is a margin headwind
Leverage scaling 0.5x to 1x debt-to-equity; refinancing risk if growth falters
Risks, ranked by how much they should concern a holder
Credibility: PAT narrative vs. delivered result mismatch
HighManagement claimed Q2 +13.5% PAT growth; delivered −32.5%. H1 claimed +32.5% conflicts with Q2 detail. Erodes confidence in forward guidance. Analysts will demand reconciliation; stock re-rates on credibility recovery.
Margin recovery timing and path unclear
HighEBITDA margin 5.7% vs. guided 5–7% is compressed. Management frames as 'transitional' but offers no specific recovery timeline. If margins stay at 5–7% beyond 3–4 quarters, the growth story is undermined and multiples compress.
Jaipur facility capex execution delay
MediumOriginally Nov–Dec, now Jan–Feb 2027. Further delays push capacity contribution into Q4 or beyond, missing FY27 margin benefit. Sets a floor on earnings credibility; another miss triggers material re-rating.
Inventory holding cost drag continues
MediumInventory at ₹13,500/gram for product launches and ramp. Carrying cost (working capital, gold price volatility) is margin headwind. Slow market absorption of new products deteriorates inventory turns and cash flow.
Leverage 0.5x → 1x without margin recovery proof
MediumDoubling debt assumes volume growth and margin recovery materialize. If growth stalls or profitability falters, debt servicing tightens. EBITDA ₹42.5 Cr; at 1x leverage, gross debt ~₹40–50 Cr; coverage weakens sharply on profit decline.
Competitive margin pressure from organized retail shift
MediumCompetitor EBITDA ~8%; Shanti 5.7%. The 2.3pp gap may reflect structural channel economics. Persistence of the gap constrains long-term ROE even at higher volumes and limits upside multiple.
How the street is positioned—and what it signals
Price action and valuation: Shanti Gold is trading at ₹272.15, down 37.8% from its all-time high of ₹437.55. The stock is below its 20-day average (₹348.53) and 50-day average (₹304.71), but above its 200-day moving average (₹234.73), suggesting a reset within a longer uptrend. RSI stands at 36.3—neutral territory, not oversold—implying more technical downside is possible if the fundamental story deteriorates. The 52-week range of ₹154.92–₹437.55 shows volatility; current levels are 75% above the low but off the highs.
Institutional positioning: FII ownership has trimmed to 1.92% from 2.18% in Q4 FY26 (−26 basis points), and DII to 1.58% from 2.13% (−55 basis points). A cumulative 81 basis-point decline in institutional holding is a heads-up—institutions are rotating out or scaling back. Promoter ownership remains stable at 74.89%. The FII/DII exits signal the market is repricing Shanti Gold's growth narrative to account for margin pressure and execution risk.
Bulk activity: Recent bulk deals show QE Securities and HRTI Private Limited trading shares near current levels (₹264–266 in early November, ₹341–344 in late October). The trading is institutional rotation—consolidation rather than panic or euphoria. No promoter/insider selling near the all-time high, which is reassuring. Activity is consistent with a market repricing, not accumulation.
Reconciliation: The market's 37.8% drawdown and institutional trim are consistent with the fundamental story. Growth is impressive, but credibility gaps and margin recovery uncertainty are material. The street is saying: Real growth, but prove the profitability story before we add.
1 · Q3 EBITDA margin and Q1 PAT reconciliation
Management must clarify the Q2 PAT narrative vs. result mismatch. Q3 must show movement toward the 5–7% EBITDA margin range. Any further compression below 5% signals structural headwinds, not temporary costs. Reconciliation of H1 vs. Q2 PAT claims is a credibility requirement.
2 · Jaipur facility operationalization (Jan–Feb 2027)
On-time operationalization at 1,200 kg annual capacity is critical to margin recovery narrative. Any further delay or ramp issues push recovery into FY28. Watch for utilization rate (target 75–80%) and product-mix contribution (designer, Turkish) from the facility in early reports.
3 · Inventory levels and working capital efficiency
Inventory at ₹13,500/gram is elevated; watch for reductions in Q3/Q4 as product launches mature and Jaipur ramps. Inventory stagnation into Q4 signals slow market absorption and extended carrying costs. Cash flow deterioration is a yellow flag.
4 · FY27 revenue trajectory vs. ₹3,200–3,500 Cr range
Volume growth (41% H1, targeting 25–30% near-term) and retail formalization are credible. Watch Q3/Q4 progression toward the range bounds. Veering toward ₹3,000 Cr or below triggers market repricing downward.
Shanti Gold is a company in transition—growth is real, but profitability is the catch. The 73% revenue surge and 41% volume expansion are exceptional, and the retail formalization tailwind is credible. But the 32.5% PAT decline and management's narrative mismatch raise hard questions about execution and cash generation. Margins are under pressure, Jaipur is delayed, and leverage is rising without proof that margin recovery is in hand.
This is a Hold—not a buy until management demonstrates it can scale volumes without margin deterioration, and not a sell because the market and organizational tailwinds are real. The single number to track from here is EBITDA margin (watch for sustained recovery toward 6–7% by Q3/Q4) and Jaipur facility utilization (target 75–80% with product-mix contribution). Credibility will be restored when Q3 earnings and call data confirm or refute the margin recovery narrative. Until then, this is a story of promise—not yet delivered.
Revenue surges 73% yet PAT collapses 32% — margin pressure masks growth
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Q2 PAT claim (13.5% growth) contradicts delivered result (−32.5%). H1 narrative (32.5% growth) conflicts with quarterly detail. EBITDA margin guidance explicitly cut.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Impressive 73% revenue growth driven by volume expansion, customer acquisition, and product diversification; however, profitability contracted 32.5% YoY and management cut EBITDA margin guidance to 5-7% from 7.5-8%. Growth is real but execution risk and margin pressure are material near-term headwinds.
₹746 Cr
Revenue · +73.4% YoY₹29.6 Cr
Reported PAT · −32.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 PAT growth 13.5% YoY
OVERSTATEDDelivered result shows PAT -32.5% YoY; Q2 FY26 actual implied ₹43.9 Cr vs mgmt's ₹26 Cr claim
H1 PAT growth 32.5% YoY
MISSIf Q2 = -32.5% and H1 = +32.5%, Q1 must have +98% growth; math inconsistent with quarterly data
Strong EBITDA growth 15.6% Q2, 29.2% H1
METEBITDA ₹42.5 Cr in Q2 confirmed; growth rate supported but margin % has compressed
Volume up 25.4% YoY Q2, 41% H1
METManagement stated 535.5 kg volume with 25.4% QoQ and 41% H1 growth; consistent narrative
FY27 revenue guidance INR 3,500 Cr unchanged
OVERSTATEDManagement revised to INR 3,200-3,500 Cr range, narrowing upper bound or cutting lower bound from prior point estimate
EBITDA margin sustainable 7.5-8%
MISSManagement now guiding 5-7%; explicit cut from prior 7.5% lower bound
Earnings quality
What changed since the last call
EBITDA margin guidance
DowngradeCut from 7.5–8% (prior call) to 5–7% (this call); reflects product mix evolution and scale-up costs, not demand weakness.
FY27 revenue range
DowngradeKept ceiling at ₹3,500 Cr but added floor of ₹3,200 Cr, narrowing from point-estimate certainty; reflects macro caution and Jaipur delay.
Jaipur facility timeline
DowngradeWas promised Nov–Dec; now Jan–Feb; interior fit-out ongoing; impacts H2 capacity contribution.
PAT margin outlook
NeutralNot explicitly restated; implied downward given EBITDA cut and continued restructuring costs, but management frames as temporary.
The Q&A
Analysts (Mahek KLM, Saurabh Gupta, Anshul Thakkar) pressed hard on margin decline despite 73% revenue growth and vs. competitors' 8% EBITDA. Management defensive, framing as 'transitional' and growth-phase cost; acknowledged inventory drag but held firm on 5-7% guidance and long-term recovery path. Tone was neutral; no concession.
H1 growth sustainability — Hina Parekh, Starklume Investments
PartialManagement attributes to customer acquisition, existing customer penetration, capacity expansion, formalization trend. Focus on market share over margins. Foundation laid; scale remains headroom.
Margin trajectory with volume — Mahek, KLM
PartialFramed as 'growth and investment phase'; new verticals and scale-up costs absorbing gains. Once utilization improves and product mix matures, margins should improve. No specific timeline given.
Jaipur facility status — Divya Daga, VG SPL
AnsweredInterior fit-out ongoing; should commence Jan or Feb (was Nov-Dec). 3-acre land, 65,000 sq ft building; 1,200 kg capacity target.
Export revenue and margin — Divya Daga, VG SPL
Answered₹82 Cr currently (4% of total); reached 6%; expected to settle 6-7% this year and grow from next year. Dubai office coming to support.
Inventory management — Prisha Shah, Shah Family Office
PartialInventory management key. In consolidation phase; more inventory, more gold, more product launches. Some buildup for product launches and facility ramp; will be supported by market expansion.
Debt and leverage headroom — Bhavya Aggarwal, Share India
AnsweredWorking capital intensive; debt required for scale. Currently 0.5x comfortable; planning to go up to 1x for growth capex. Additional headroom available if market requires.
Sustainable EBITDA margin — Lavita Lasrado, Bank of Baroda Capital
PartialCompetitor EBITDA ~8%; Shanti 5.7% currently. Core margin resilient; gold passes through. Price equilibrium at market level; business model robust. Margin correction coming as scale, utilization improve.
Volume growth and capex utilization — Preeyam Tolia, Choice Institutional Equities
PartialHistorically CAGR 43%; near-term 25-30% comfortable. Jaipur will add product mix leverage. At 75-80% utilization, margins should improve. Inventory will be tied up initially but supported by growth.
Hedging policy and gold price sensitivity — Anshul Thakkar, Thakkar Investments
AnsweredRisk management via natural hedging and inventory discipline. Price equilibrium at market; buy at every level, sell at every level. 80% of inventory gains offset. Core margin intact regardless of price.
Competitive positioning and product strategy — Saurabh Gupta, Kenvi Capital
PartialLeading manufacturer; Marol/Jaipur gateways expand. Product mix driving margin evolution. Advanced gold coming. Not considering merger; separate management, no overlap. Scale growing organically.
Long-term vision and capex plan — Saurabh Gupta, Kenvi Capital
Partial100% confidence in reaching INR 10,000 Cr. Jaipur: 3 acres, can scale facility over time. Foundation set; roadmap in place. Next con-call can provide 3-5 year vision.
Advanced gold expansion — Ayush Aggarwal, Asset Yogi
DodgedLooking forward to advanced gold; maybe in coming years. Ratnayeer investment is treasury deployment, not strategic diversification. Core business focus remains.
Guidance
FY27 ₹3,200–3,500 Cr (revised; prior ₹3,500 Cr point estimate)
MediumVolume CAGR 43% historical, 25-30% near-term; 50-60% value growth assumed. Macro caution and Jaipur delay drove range widening/lower-bound addition.
EBITDA margin 5-7% (cut from prior 7.5-8%)
MediumTemporary inventory/scale-up cost absorption; margin recovery as product mix matures, utilization improves, Jaipur operationalizes (75-80% target).
Core PAT margin ~4% (not explicitly restated; implied from EBITDA cut)
LowPrior 4% guidance no longer stated; gold price pass-through hedges price movements; margin 'resilient' per mgmt but not quantified forward.
Jaipur: ₹47 Cr total; operational Jan-Feb 2027 (was Nov-Dec)
MediumInterior fit-out ongoing; 3-acre land, 65,000 sq ft facility; 1,200 kg annual capacity; will add product mix and margin leverage.
Risks the call surfaced
Margin compression structural
HighEBITDA margin fell from guided 7.5-8% to 5.7% actual; management attributes to inventory costs, new verticals, and scale-up. Not clear if transient or structural shift.
Capex execution risk
MediumJaipur facility interior fit-out ongoing; promised Nov-Dec, now Jan-Feb. Further delays would push capacity addition into H2/Q4, reducing FY27 contribution.
Leverage increase
MediumManagement planning to double leverage to 1x debt-equity to fund Jaipur, Dubai, inventory. If revenue growth stalls or margins don't recover, debt servicing could tighten.
Inventory holding cost drag
MediumInventory ₹13,500 per gram; buildup for product launches and Jaipur ramp. Carrying cost (funding, insurance, gold price volatility) is margin headwind.
Gold price sensitivity
LowGold prices fell 6-7% in the call period. While mgmt claims 80% pass-through and core margin resilience, retail order absorption may weaken if prices continue to fall.
Management
Score 6/10. Moderately clear; hedged on near-term but transparent on challenges. Acknowledged inventory costs, margin pressure, facility delays. Did not avoid tough questions but deferred specifics (advanced gold %, merger, capex timeline). Mixed track record. Revenue growth (73% Q2, 102% H1) excellent; profitability decline (−32.5% PAT) and margin compression problematic. Jaipur delayed from Nov-Dec to Jan-Feb. Rights issuance completed on time.
1 · Jan–Feb 2027
Jaipur facility operational; 1,200 kg additional capacity to ease inventory, margin relief
2 · H2 FY27
Dubai office launch; export revenue push from 4-6% to 6-7% of total
3 · H2 FY27
Product mix maturation; new verticals (advanced gold, designer, Turkish) scaling; margin recovery expected
Growth is real but execution risk and margin pressure are material near-term headwinds.